GEODE CAPITAL MANAGEMENT, LLC - BELLICUM PHARMACEUTICALS INC ownership

BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 83 filers reported holding BELLICUM PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 2.03 and the average weighting 0.1%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of BELLICUM PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$1,074,000
+190.3%
832,898
+136.2%
0.00%
Q3 2019$370,000
-38.5%
352,585
-0.6%
0.00%
Q2 2019$602,000
-65.6%
354,660
-31.6%
0.00%
Q1 2019$1,748,000
-41.2%
518,714
-49.1%
0.00%
Q4 2018$2,974,000
+13.7%
1,018,620
+139.8%
0.00%
-100.0%
Q3 2018$2,616,000
-11.4%
424,793
+6.1%
0.00%0.0%
Q2 2018$2,953,000
+97.9%
400,232
+75.9%
0.00%
Q1 2018$1,492,000
-20.9%
227,502
+1.4%
0.00%
-100.0%
Q4 2017$1,887,000
-26.1%
224,418
+1.4%
0.00%0.0%
Q3 2017$2,555,000
+8.4%
221,273
+9.6%
0.00%0.0%
Q2 2017$2,357,000
+6.7%
201,801
+12.7%
0.00%0.0%
Q1 2017$2,209,000
+6.9%
179,012
+17.9%
0.00%0.0%
Q4 2016$2,067,000
-36.9%
151,811
-7.8%
0.00%
-50.0%
Q3 2016$3,276,000
+211.4%
164,638
+102.8%
0.00%
+100.0%
Q2 2016$1,052,000
+74.2%
81,189
+25.6%
0.00%
Q1 2016$604,000
-52.0%
64,665
+4.0%
0.00%
-100.0%
Q4 2015$1,259,000
+38.2%
62,152
-0.9%
0.00%0.0%
Q3 2015$911,000
-43.1%
62,698
-16.7%
0.00%0.0%
Q2 2015$1,601,000
-7.2%
75,286
+1.0%
0.00%0.0%
Q1 2015$1,726,00074,5090.00%
Other shareholders
BELLICUM PHARMACEUTICALS INC shareholders Q2 2017
NameSharesValueWeighting ↓
Virtus ETF Advisers LLC 15,086$306,0000.84%
Baker Brothers Advisors 4,865,647$98,627,0000.82%
Cormorant Asset Management, LP 300,000$6,081,0000.73%
SPHERA FUNDS MANAGEMENT LTD. 231,515$4,693,0000.69%
QVT Financial LP 340,986$6,912,0000.39%
Graticule Asia Macro Advisors LLC 87,000$1,763,0000.29%
Hatteras Investment Partners, LP 10,410$211,0000.28%
MCDANIEL TERRY & CO 33,836$686,0000.18%
Highlander Capital Management, LLC 6,500$132,0000.12%
EverPoint Asset Management, LLC 265,000$5,372,0000.11%
View complete list of BELLICUM PHARMACEUTICALS INC shareholders